Can parathyroid hormone be used as a biomarker for heart failure?

PubWeight™: 0.76‹?›

🔗 View Article (PMID 22875486)

Published in Heart Fail Rev on July 01, 2013

Authors

Sumeet Gandhi1, Robert B H Myers

Author Affiliations

1: Department of Medicine, University of Toronto, Toronto, ON, Canada.

Articles cited by this

Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr (2004) 5.88

Biomarkers in heart failure. N Engl J Med (2008) 5.20

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation (1991) 4.89

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol (2006) 3.20

Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrol Dial Transplant (2011) 2.60

Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol (2011) 2.56

Aldosterone in congestive heart failure. N Engl J Med (2001) 2.46

Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol (2009) 2.13

Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation (2007) 1.95

Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study. J Clin Endocrinol Metab (1996) 1.79

Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation (2007) 1.69

Metabolic alkalosis. J Am Soc Nephrol (2000) 1.63

Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest (1997) 1.54

On the rise: The current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol (2003) 1.54

New insights about vitamin D and cardiovascular disease: a narrative review. Ann Intern Med (2011) 1.46

National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. Circulation (2007) 1.39

Treating the right patient at the right time: access to heart failure care. Can J Cardiol (2006) 1.36

Parathyroid hormone and vitamin D--markers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail (2011) 1.33

Basic and clinical concepts related to vitamin D metabolism and action (second of two parts). N Engl J Med (1977) 1.21

Osteitis fibrosa cystica simulating metastatic tumor. An almost-forgotten relationship. Am J Clin Pathol (1993) 1.12

Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study. Eur J Cardiovasc Prev Rehabil (2004) 1.08

Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail (2010) 1.05

Dietary NaCl loads promote calciuria and bone loss in adult oophorectomized rats consuming a low calcium diet. J Nutr (1983) 0.95

Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab (2000) 0.91

Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem J (1995) 0.91

Serum intact parathyroid hormone levels predict hospitalisation for heart failure. Heart (2008) 0.89

Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Arch Gerontol Geriatr (2008) 0.89

Inpatient monitoring and prognostic importance of B-type natriuretic peptide. Congest Heart Fail (2008) 0.89

Congestive heart failure: where homeostasis begets dyshomeostasis. J Cardiovasc Pharmacol (2010) 0.88

Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease. Kidney Int Suppl (2005) 0.87

Parathyroid hormone-parathyroid hormone related protein receptor messenger RNA is present in many tissues besides the kidney. Am J Nephrol (1993) 0.86

Vitamin D in chronic heart failure. Curr Heart Fail Rep (2011) 0.84

Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure. J Endocrinol Invest (2010) 0.83

Parathyroid hormone gene variant and calcific aortic stenosis. J Heart Valve Dis (2009) 0.80

Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential. Circulation (1997) 0.79

Relation of serum parathyroid hormone level to severity of heart failure. Am J Cardiol (2011) 0.78

Signaling pathway and chronotropic action of parathyroid hormone in isolated perfused rat heart. J Cardiovasc Pharmacol (2001) 0.78

Calcium and vitamin D status in heart failure patients in Isfahan, Iran. Biol Trace Elem Res (2009) 0.78

Microscopic bone pathology in two cases of surgically treated secondary hyperparathyroidism. Report of a distinct skeletal lesion. Am J Surg Pathol (1987) 0.75

Vitamin D receptors and parathyroid glands. Endocr Pract (2011) 0.75

Serum intact parathyroid hormone levels independently predict exercise capacity in stable heart failure patients. Int J Cardiol (2010) 0.75